SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
144 hedge funds and large institutions have $911M invested in Sage Therapeutics in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 27 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $927M → $911M (-$16M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
144
Holding in Top 10
7
Calls
$66.8M
Puts
$46.1M
Top Buyers
| 1 | +$19M | |
| 2 | +$13M | |
| 3 | +$12.6M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$10.8M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$9.94M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$35.7M | |
| 3 | -$33.8M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.48M |